作者: Jeffrey A. Wilken , Robert L. Kane , Anne K. Ellis , Elizabeth Rafeiro , Maureen P. Briscoe
DOI: 10.1016/S1081-1206(10)61685-7
关键词: Allergy 、 Diphenhydramine 、 Placebo 、 Vigilance (psychology) 、 Anesthesia 、 Environmental exposure 、 Ragweed 、 Antihistamine 、 Medicine 、 Desloratadine
摘要: Background Decrements in cognitive performance are associated with the use of sedating antihistamines. Most, but not all, second-generation antihistamines have been found to be nonsedating. Objective To examine central nervous system (CNS) profile a new antihistamine, desloratadine. Methods Subjects ragweed-induced allergic rhinitis (aged 18–60 years) who demonstrated predetermined severity symptoms after priming ragweed pollen Environmental Exposure Unit were randomized receive single dose desloratadine, 5 mg; diphenhydramine, 50 or placebo. A comprehensive battery repeatable, automated neuropsychological tests was administered subjects before treatment (symptomatic baseline) and 90 minutes taking study medication. Results Both desloratadine ( P = .04) diphenhydramine Conclusions Desloratadine improved without adversely affecting performance. Diphenhydramine caused significant decrements vigilance functioning. Thus, efficacy antihistamine must balanced against effects on CNS